DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Honda A, Ikegami T, Nakamuta M. , et al.
Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid.
Hepatology 2013;
57 (05) 1931-1941
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.